In a 104-week extension, patients reached 30.3%
This helps your clinician understand if your current dosage is right for you and gives you the opportunity to share any health changes, side effects, or medication preferences
This might look like eggs and Greek yogurt at breakfast, chicken or fish with vegetables at lunch, and a protein-rich dinner with beans, tofu, or meat
Litigation against the manufacturer is ongoing but is anticipated to grow significantly in the coming weeks and months as more affected individuals come forward
Among the most promising non-incretin receptor targets are amylin (Amy) receptors (AMYRs), supported by data from phase I and phase II clinical trials showing efficacy of the long-acting amylin and calcitonin receptor agonist, cagrilinitide (Cagri), both as monotherapy 2,3 and in combination with the selective GLP-1R agonist, semaglutide 4,5
This mechanism of action, combined with its proven effectiveness, distinguishes Semaglutide from other medications
